Agape ATP Corporation (NASDAQ:ATPC) Short Interest Update

Agape ATP Corporation (NASDAQ:ATPC) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totaling 5,215 shares, a decrease of 46.0% from the April 30th total of 9,663 shares. Based on an average trading volume of 67,588 shares, the short-interest ratio is currently 0.1 days. Currently, 0.5% of the shares of the company are short sold.

Institutional Trading of Agape ATP

A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC lifted its stake in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. Institutional investors and hedge funds own 0.01% of the company’s stock.

Analyst Upgrades and Downgrades

ATPC has been the topic of a number of research analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Agape ATP has an average rating of “Sell”.

Agape ATP Trading Down 27.9%

ATPC stock traded down $1.16 during trading hours on Tuesday, hitting $2.99. 1,222,865 shares of the stock were exchanged, compared to its average volume of 5,919,363. The firm has a market capitalization of $2.99 million, a P/E ratio of -2.91 and a beta of 0.05. The company has a 50-day simple moving average of $2.71 and a two-hundred day simple moving average of $12.06. Agape ATP has a 12 month low of $1.72 and a 12 month high of $85.50.

Agape ATP (NASDAQ:ATPC) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.33) earnings per share for the quarter. The firm had revenue of $0.27 million for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.